Study guide

20.4 Corneal Pachymetry, Endothelial Specular Microscopy & Anterior Chamber Depth

IJCAHPO Certified Ophthalmic Medical Technologist COMT

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: The COMT Examination, Eligibility & Certification Requirements

1.1 The 190-Question Multiple-Choice Examination & the 22 Official Content Areas 1.2 The COT Skill Evaluation & the COMT Performance Test 1.3 Eligibility Pathways, Fees, Timelines & Recertification

2 Chapter 2: General Medical Knowledge I — Ocular Anatomy & Physiology

2.1 Orbit, Eyelids, Lacrimal System, Conjunctiva & Extraocular Muscles 2.2 Cornea, Sclera, Anterior Chamber, Angle, Aqueous Dynamics & Crystalline Lens 2.3 Uvea, Retina, Vitreous, Optic Nerve, Ocular Circulation & the Visual Pathway

3 Chapter 3: General Medical Knowledge II — Eye Disease, Systemic Manifestations, Terminology & Safety

3.1 Frequently Encountered Eye Conditions by Structure & Inflammation Versus Infection 3.2 Body Systems & the Ocular Manifestations of Systemic Disease 3.3 Medical Terminology, Approved Abbreviations, Hazardous Waste & Clinic Safety

4 Chapter 4: Ophthalmic History Taking & Clinical Documentation

4.1 The Five History Domains: Ocular, Medical, Medication, Social & Family 4.2 Charting Conventions, Scribing & the Electronic Medical Record

5 Chapter 5: Visual Assessment, Accommodative Testing & Low Vision

5.1 Measuring Acuity at Every Level & in Preliterate, Illiterate and Non-Verbal Patients 5.2 Stereoacuity, Near Point of Accommodation, Near Point of Convergence & the AC/A Ratio 5.3 Low Vision Assessment, Magnification Calculation & Device Instruction

6 Chapter 6: Tonometry, Keratometry & Pupil Measurement

6.1 Goldmann Applanation Tonometry: Technique, Sources of Error & the Imbert-Fick Principle 6.2 Hand-Held Applanators, Non-Contact Tonometry, Rebound Tonometry & Disinfection 6.3 Manual & Automated Keratometry: Technique, Readings and Interpretation 6.4 Pupil Measurement, Shape, Reactivity & Evaluating Anisocoria

7 Chapter 7: Lensometry, Spectacle Optics & Prescription Analysis

7.1 Manual Lensometry: Eyepiece Focus, Neutralising Sphere, Cylinder & Axis 7.2 Neutralising Reading Adds: Bifocal, Trifocal, Progressive & Determining the Near Add 7.3 Identifying & Measuring Prism: Ground-In, Decentration, Fresnel Press-On & Slab-Off 7.4 Transposition, Spherical Equivalent, Vertex Distance & Prescription Components 7.5 The Geneva Lens Clock, Lens Materials, Progressive Markings & Spectacle Adjustment

8 Chapter 8: Refraction, Retinoscopy & Refinement

8.1 Autorefraction, Refractive Error Types & Establishing an Objective Starting Point 8.2 Streak Retinoscopy: With Motion, Against Motion, Neutralisation & Working Distance 8.3 Subjective Refinement: Fogging, Jackson Cross Cylinder, Duochrome & Binocular Balance 8.4 Near Add Determination, Vertex Recording & Refraction in Difficult Situations

9 Chapter 9: Ocular Motility, Strabismus & Advanced Optics

9.1 Ocular Kinematics: Ductions, Versions, Vergences, Hering's & Sherrington's Laws 9.2 Quantitative Strabismus Measurements: Alternate Cover Test, Prism Cover Test & Lancaster Red-Green / Hess Screen 9.3 Cranial Nerve Palsies (CN III, IV, VI), Restrictive Myopathies & Forced Duction Testing 9.4 Clinical Optics, Prentice's Rule, Slab-Off Prisms & Wavefront Aberrations

10 Chapter 10: Sensory Fusion Testing, Nystagmus, Amblyopia & Vergence Therapy

10.1 Sensory Fusion Testing: Worth 4-Dot, Maddox Rod & Bagolini Lenses 10.2 Hirschberg, Krimsky, Brückner & Fusional Vergence Amplitudes 10.3 Nystagmus, Amblyopia Therapy & Convergence Training

11 Chapter 11: Advanced Visual Fields & Neuro-Ophthalmic Evaluation

11.1 Amsler Grid & Confrontation Visual Field Testing 11.2 Automated Static Perimetry: HFA Strategies (SITA Standard, SITA Fast), Reliability Indices & Statpac Analysis 11.3 Visual Field Defect Patterns: Glaucomatous Nerve Fiber Bundle Deficits vs. Retinal Pathology 11.4 Kinetic Perimetry (Goldmann Perimetry) & Neurological Visual Pathway Defect Localization 11.5 Pupillary Pathways, RAPD Quantitation with Neutral Density Filters & Pharmacologic Testing

12 Chapter 12: Supplemental Testing — Glare, PAM, Colour Vision, Tear Film & Slit Lamp Technique

12.1 Glare Testing, Potential Acuity Meter & Contrast Sensitivity 12.2 Colour Vision: Pseudoisochromatic Plates, Farnsworth-Munsell D-15 & the 100-Hue Test 12.3 Tear Film Assessment: Schirmer, Tear Break-Up Time, Vital Dyes & Corneal Sensitivity 12.4 Slit Lamp Technique, Slit Lamp Lenses, Direct Ophthalmoscopy & Pen Light Examination 12.5 Exophthalmometry, Head & Posture Assessment and Wavefront Diagnostics

13 Chapter 13: Full-Field Electroretinography & ISCEV Protocols

13.1 Retinal Neurophysiology & Electrophysiologic Origin of Waveforms 13.2 ISCEV Standard Full-Field ERG Protocol & Electrode Systems 13.3 Dark-Adapted (Scotopic) Testing: Rod-Driven Responses & Combined Maximal Response 13.4 Light-Adapted (Photopic) Testing: Cone Response, 30-Hz Flicker & Oscillatory Potentials

14 Chapter 14: Advanced Electrophysiologic Testing (mfERG, PERG, VEP, EOG)

14.1 Multifocal Electroretinogram (mfERG): Topographic Retinal Mapping 14.2 Pattern Electroretinogram (PERG): Ganglion Cell & Macular Function 14.3 Visual Evoked Potentials (VEP): Flash, Pattern & Visual Pathway Integrity 14.4 Electrooculogram (EOG), Arden Ratio & RPE Light Peak Dynamics

15 Chapter 15: Fluorescein Angiography Principles & Technique

15.1 Fluorescein Angiography Principles, Exciter/Barrier Filters & Injection Protocol 15.2 Normal Transit Phases & Retinal/Choroidal Circulation Hemodynamics 15.3 Adverse Reactions, Patient Safety & Emergency Management

16 Chapter 16: Angiographic Interpretation & Pathology

16.1 Hyperfluorescence Mechanisms: Leakage, Staining, Pooling, Window Defects & Autofluorescence 16.2 Hypofluorescence Mechanisms: Vascular Non-Perfusion & Blocking Defects 16.3 Indocyanine Green (ICG) Angiography: Principles, Indications & Choroidal Pathology

17 Chapter 17: Advanced Fundus Imaging & Optical Coherence Tomography

17.1 Fundus Autofluorescence (FAF) & Ultra-Widefield Fundus Imaging 17.2 Spectral-Domain and Swept-Source OCT: Retinal Layer Architecture & Quantitative Analysis 17.3 Enhanced Depth Imaging (EDI-OCT) & Anterior Segment OCT (AS-OCT) 17.4 Optical Coherence Tomography Angiography (OCTA): Chorioretinal Plexuses & Biomarkers

18 Chapter 18: Ophthalmic Photography & Videography

18.1 The Fundus Camera: Optics, Alignment & Correcting Artefacts 18.2 Standard Fundus Photography: ETDRS Fields, Stereo Pairs, Red-Free & Wide-Field Imaging 18.3 Slit Lamp & Anterior Segment Photography 18.4 External Photography, Nine-Gaze Motility Documentation & Image Management

19 Chapter 19: Ophthalmic Echography (A-Scan, B-Scan & UBM)

19.1 Physics of Ophthalmic Ultrasound, Acoustic Impedance & Probe Transducers 19.2 Standardized Diagnostic A-Scan: Acoustic Spikes, Tissue Reflectivity & Attenuation 19.3 Diagnostic B-Scan Echography: Topographic, Kinetic & Quantitative Vitreoretinal Evaluation 19.4 Ultrasound Biomicroscopy (UBM): Anterior Segment Anatomy, Angle Pathology & Ciliary Body Imaging

20 Chapter 20: Biometry, Topography & Corneal Analysis

20.1 Optical Biometry vs. Immersion/Contact Ultrasound Biometry 20.2 Intraocular Lens (IOL) Power Calculation Formulas & Post-Refractive Adjustments 20.3 Corneal Topography, Scheimpflug Tomography & Keratoconus Screening 20.4 Corneal Pachymetry, Endothelial Specular Microscopy & Anterior Chamber Depth

21 Chapter 21: Rigid Gas Permeable & Specialty Lens Fitting

21.1 Rigid Gas Permeable (RGP) Material Properties, Dk/t & Oxygen Permeability 21.2 RGP Base Curve Selection, Diagnostic Fitting & Fluorescein Pattern Evaluation 21.3 Scleral Contact Lens Design, Sagittal Depth Fitting & Clearance Evaluation 21.4 Keratoconus, Irregular Corneas & Hybrid Contact Lens Systems

22 Chapter 22: Toric, Multifocal, Therapeutic Lenses & Complications

22.1 Toric Soft Contact Lens Dynamics, Stabilization Techniques & LARS Rule 22.2 Presbyopic & Multifocal Contact Lens Systems: Simultaneous vs. Translating Designs 22.3 Therapeutic Bandage Contact Lenses, Amniotic Membranes & Orthokeratology 22.4 Contact Lens-Induced Pathology, Giant Papillary Conjunctivitis & Infectious Keratitis

23 Chapter 23: Ocular Pharmacology

23.1 Routes of Drug Delivery, Prescription Components & Instillation Technique 23.2 Mydriatics, Cycloplegics, Anaesthetics & Diagnostic Agents 23.3 Glaucoma Medications: Classes, Mechanisms & Side Effects 23.4 Anti-Infectives, Corticosteroids, NSAIDs, Allergy Agents, Lubricants, Supplements & Anti-VEGF

24 Chapter 24: Microbiology & Ocular Specimen Collection

24.1 Types of Microorganisms & Pathways of Disease Transmission 24.2 Assisting with Conjunctival & Corneal Specimen Collection

25 Chapter 25: Anterior Segment, Glaucoma & Refractive Surgery

25.1 Advanced Phacoemulsification, Surgical Steps, Fluidics & Complication Management 25.2 Premium Intraocular Lenses: Toric, Multifocal, EDOF & Lens Exchange 25.3 Glaucoma Surgical Procedures: Trabeculectomy, Aqueous Shunts & MIGS Devices 25.4 Laser In Situ Keratomileusis (LASIK), PRK, SMILE & Phakic IOLs

26 Chapter 26: Vitreoretinal, Corneal & Trauma Surgery

26.1 Pars Plana Vitrectomy (PPV), Scleral Buckling & Intraocular Tamponades (Gas/Silicone Oil) 26.2 Corneal Transplantation: Penetrating Keratoplasty (PKP) & Lamellar Keratoplasty (DSAEK, DMEK, DALK) 26.3 Ocular Trauma Repair: Open Globe Management, Hyphema, Vitreous Loss & Endophthalmitis Protocol

27 Chapter 27: Surgical Asepsis, Instrumentation & Laser Procedures

27.1 Operating Room Sterilization, Aseptic Field Maintenance & Universal Precautions 27.2 Microsurgical Instrumentation, Maintenance & Sharps Safety 27.3 Ophthalmic Laser Physics, Delivery Systems & Safety (Nd:YAG, Argon/FD-Nd:YAG, SLT)

28 Chapter 28: Ophthalmic Patient Services & Education

28.1 Communicating with Patients, Families and Colleagues, and Handling Dissatisfaction 28.2 Patient Education & Counselling on Conditions, Medications, Tests and Results 28.3 Ophthalmic Emergencies, First Aid, Vital Signs & CPR 28.4 Triage, Urgency-Based Scheduling, Patient Flow & Telephone Management 28.5 Dressings and Shields, Prosthetics, Legal Forms, Referrals & Reimbursement Support

29 Chapter 29: Clinic Operations — Equipment Maintenance, Ethics, Coding & Compliance

29.1 Equipment Maintenance, Calibration, Emergency Equipment & Inventory 29.2 Confidentiality, Informed Consent, Scope of Practice & Ethical Standards 29.3 Coding, Scribing Compliance, Quality Assurance & Regulatory Requirements

20.4 Corneal Pachymetry, Endothelial Specular Microscopy & Anterior Chamber Depth

Key Takeaways Explain This Topic AI

Ultrasound pachymetry calibrates corneal acoustic velocity to 1640 m/s; normal central corneal thickness (CCT) averages 540 to 555 µm, and oblique probe tilt artificially prolongs sound transit, yielding a falsely thick reading.

Goldmann applanation tonometry (GAT) assumes a CCT of 520 to 545 µm; thin corneas (<520 µm) underestimate true IOP, masking glaucoma progression, and thin CCT (≤555 µm) is a validated major independent risk factor for POAG progression in the OHTS trial.

In laser refractive surgery, preserving a residual stromal bed (RSB) of at least 250 µm (preferably ≥300 µm) and avoiding a percentage of tissue altered (PTA) ≥40% are essential mandates to prevent postoperative keratoectasia.

Corneal endothelial specular microscopy evaluates baseline cell density (ECD, 2500–3000 cells/mm² in adults), coefficient of variation (CV <0.30, polymegathism), and hexagonality (>60%, pleomorphism); cell counts <500 cells/mm² reach the threshold for clinical decompensation and bullous keratopathy.

Anterior chamber depth (ACD) averages 3.0 to 3.5 mm; an ACD <2.5 mm warns of angle-closure risk, creates high surgical risk for endothelial acoustic trauma during phacoemulsification, and contraindicates anterior chamber phakic IOL implantation.

Last updated: September 2026

Corneal Pachymetry, Endothelial Specular Microscopy & Anterior Chamber Depth

Core Clinical Mandate: Accurate quantitative assessment of corneal thickness, endothelial cell viability, and anterior chamber depth is foundational to clinical ophthalmic practice. These three biometric parameters govern intraocular pressure interpretation in glaucoma management, dictate surgical safety margins in refractive surgery, predict corneal endothelial survival following phacoemulsification, and guide premium/phakic IOL candidacy. COMT candidates must possess exhaustive knowledge of instrument calibration, normal morphometric thresholds, and pathological failure states.

Corneal Pachymetry Principles and Biometric Instrumentation

Pachymetry is the measurement of corneal thickness. The human cornea is thinnest centrally and thickens progressively toward the periphery (limbus).

Ultrasound Pachymetry Calibration and Technique

Acoustic Velocity in Corneal Tissue: Ultrasound pachymeters utilize a high-frequency solid probe (typically 20 to 50 MHz). Sound propagates through the organized, tightly packed collagen lamellae of the corneal stroma at a calibrated velocity of 1640 m/s (significantly faster than the 1532 m/s of aqueous or vitreous humor).

The Probe Perpendicularity Mandate: The ultrasound probe must be applied at exact 90° normal incidence to the center of the anterior cornea under topical anesthesia. If the probe is angled obliquely, the acoustic beam travels across a longer, non-perpendicular diagonal path through the stroma, resulting in an artificially elevated (falsely thick) pachymetry reading .

Epithelial Displacement: Excessive mechanical pressure can compress or displace the corneal epithelium, falsely thinning the measurement.

Normal Population Baselines: Normal central corneal thickness (CCT) in healthy adults averages 540 to 555 µm (standard deviation ± 30 µm). Peripheral corneal thickness at the limbus averages 650 to 700 µm.

Optical, Scheimpflug, and OCT Pachymetry

Modern non-contact imaging systems (Anterior Segment OCT, Scheimpflug Pentacam, and OLCR biometers) generate optical pachymetric maps without touching the eye:

Advantages: Eliminates topical anesthetic toxicity, eliminates probe compression artifacts, removes the risk of cross-infection, and maps thickness continuously across the entire 12-mm corneal diameter to pinpoint the exact location and coordinates of the thinnest point.

  • Clinical Impact of Pachymetry in Glaucoma and Refractive Surgery
  • 1. Pachymetry in Glaucoma and the OHTS Landmark Findings

Goldmann Applanation Tonometry (GAT) is the international gold standard for measuring intraocular pressure (IOP). GAT operates on the Imbert-Fick physical principle , which states that the internal pressure inside an ideal, infinitely thin, dry spherical membrane equals the force required to flatten a given area: W = P t ⋅ A W = P_t · A W = P t ​ ⋅ A

In engineering the GAT tonometer tip to applanate a circular diameter of 3.06 mm , Hans Goldmann calibrated the system based on an assumed average human CCT of 520 to 545 µm .

The Thin Cornea Pitfall ( C C T < 520 CCT < 520 CCT < 520 µm): A thin cornea offers less physical structural resistance to mechanical indentation. The tonometer applanates the 3.06 mm circle prematurely with less applied force. The instrument records an artificially low IOP reading, masking progressive glaucomatous damage.

The Thick Cornea Pitfall ( C C T > 580 CCT > 580 CCT > 580 µm): A thick cornea possesses high structural rigidity, requiring greater mechanical force to applanate. The tonometer records an artificially high IOP reading , frequently leading to a false-positive diagnosis of ocular hypertension or glaucoma in a healthy eye.

The Ocular Hypertension Treatment Study (OHTS): This landmark multicenter randomized trial established that thin central corneal thickness (≤ 555 µm) is a powerful, independent predictor of the progression from ocular hypertension to primary open-angle glaucoma (POAG) . Patients with ocular hypertension and CCT ≤ 555 µm had roughly three times the risk of developing glaucoma compared to those with CCT > 588 µm.

2. Pachymetry in Laser Refractive Surgery (LASIK / PRK)

In excimer laser corneal refractive surgery, stromal tissue is permanently removed via photoablation. Preoperative pachymetry determines whether sufficient tissue exists to maintain corneal biomechanical stability.

Residual Stromal Bed (RSB): The remaining unablated posterior stroma located beneath the LASIK flap: R S B = C C T − Flap Thickness − Ablation Depth RSB = CCT - \text{Flap Thickness} - \text{Ablation Depth} RSB = CCT − Flap Thickness − Ablation Depth

The Absolute Safety Thresholds:

Minimum RSB: The absolute universally accepted minimum RSB is 250 µm (with many refractive surgeons enforcing a conservative threshold of ≥ 300 µm ).

Percentage of Tissue Altered (PTA): Formulated by Santhiago et al., PTA quantifies the proportion of biomechanically active tissue modified by flap creation and ablation: P T A = Flap Thickness + Ablation Depth C C T PTA = \frac{\text{Flap Thickness} + \text{Ablation Depth}}{CCT} PT A = CCT Flap Thickness + Ablation Depth ​

A P T A ≥ 40 % PTA ≥ 40\% PT A ≥ 40% is the single most robust individual risk factor for developing post-LASIK iatrogenic keratoectasia in corneas with normal preoperative topography.

Loading diagram... Corneal Endothelial Risk Stratification and Surgical Decision Tree

  • Endothelial Specular Microscopy: Physiology and Morphometric Metrics
  • The Corneal Endothelial Monolayer

The corneal endothelium is a single layer of specialized cells covering the posterior surface of Descemet's membrane. Unlike the corneal epithelium, human endothelial cells possess virtually zero mitotic capacity in vivo . Endothelial cells do not divide. When cells are lost due to aging, trauma, or surgery, neighboring cells must enlarge (polymegathism) and stretch or reshape (pleomorphism) to cover the bare areas of Descemet's membrane.

The Endothelial Pump-Leak Mechanism

The primary physiological function of the endothelium is to maintain the cornea in a state of relative dehydration ( deturgescence ), which is mandatory for optical transparency. The stroma contains hydrophilic glycosaminoglycans that naturally imbibe aqueous humor (leak). The endothelial cells counteract this swelling through active N a + / K + Na^+/K^+ N a + / K + ATPase metabolic pumps coupled with bicarbonate transport, continuously driving fluid out of the stroma back into the anterior chamber.

1. Endothelial Cell Density (ECD)

Expressed as the number of endothelial cells per square millimeter (cells/mm²):

  • Normal Young Adult: 3000 to 3500 cells/mm²
  • Normal Middle-Aged / Older Adult: 2000 to 2500 cells/mm²

Normal Annual Physiological Attrition: ~0.5% to 0.6% per year across a normal lifetime.

The Critical Decompensation Threshold: When cell density falls below 300 to 500 cells/mm² , the metabolic pump capacity is overwhelmed by passive fluid leakage. The cornea loses deturgescence, swelling rapidly to develop stromal edema, epithelial microcysts, and painful epithelial blisters ( Pseudophakic Bullous Keratopathy [PBK] ).

Cataract Surgery Safety Threshold: Phacoemulsification routinely induces a 5% to 15% surgical endothelial cell loss (due to ultrasound acoustic cavitation, mechanical turbulence, and nuclear fragment contact). A preoperative ECD < 1000 cells/mm² indicates high surgical risk, requiring soft shell dispersive ophthalmic viscosurgical devices (OVD) and minimized phaco energy.

2. Coefficient of Variation (CV) — Polymegathism (Cell Size Variation)

Mathematical Definition: The coefficient of variation is calculated as the standard deviation of individual cell surface areas divided by the mean cell area ( C V = S D / Mean Area CV = SD / \text{Mean Area} C V = S D / Mean Area ).

Normal Baseline: In healthy young corneas, endothelial cells are uniform in size, yielding a C V < 0.30 CV < 0.30 C V < 0.30 (or < 30 % < 30\% < 30% ).

Clinical Significance: A C V > 0.33 to 0.40 CV > 0.33\text{ to } 0.40 C V > 0.33 to 0.40 indicates significant polymegathism . High polymegathism is an early, highly sensitive biomarker of endothelial metabolic stress, chronic hypoxia (e.g., long-term rigid or low-Dk contact lens overwear), or early allograft rejection, occurring even before absolute cell density drops.

3. Hexagonality (6A%) — Pleomorphism (Cell Shape Variation)

Mathematical Definition: The percentage of endothelial cells that retain the normal, geometrically stable six-sided (hexagonal) shape.

Normal Baseline: In a pristine endothelial mosaic, > 60 % > 60\% > 60% of cells are six-sided.

Clinical Significance: Values < 50 % < 50\% < 50% indicate marked pleomorphism . This reflects structural reorganization, where five-sided, seven-sided, or irregular polygonal cells replace the normal hexagonal honeycomb mosaic, compromising structural barrier integrity.

Cornea Guttata and Fuchs' Endothelial Dystrophy (FECD)

Pathophysiology: In Fuchs' Endothelial Corneal Dystrophy (FECD) , dysfunctional endothelial cells secrete abnormal collagenous excrescences onto the posterior surface of Descemet's membrane, known as guttae (or guttata) .

Specular Microscopic Appearance: Guttae appear as dark, non-reflective central voids or "drop-out" areas surrounded by compressed, distorted endothelial cells. Because the specular beam reflects off flat interfaces, the rounded, mushroom-shaped guttae scatter light away from the camera, casting acoustic/optical shadows that prevent automated software cell counting.

In advanced FECD with dense confluent guttae and stromal edema, endothelial keratoplasty ( DMEK or DSAEK ) is indicated.

  • Anterior Chamber Depth (ACD) Dynamics in Ophthalmic Biometry
  • Optical ACD vs. Internal (Aqueous) ACD

Technologists must distinguish between two definitions of anterior chamber depth:

Optical ACD: Measured from the anterior corneal epithelium to the anterior crystalline lens capsule (includes corneal thickness).

Internal (Aqueous) ACD: Measured from the posterior corneal endothelium to the anterior lens capsule ( A C D i n t e r n a l = A C D o p t i c a l − C C T ACD_{internal} = ACD_{optical} - CCT A C D in t er na l ​ = A C D o pt i c a l ​ − CCT ).

Clinical Thresholds and Diagnostic Significance

Normal Adult Range: Optical ACD typically measures 3.0 to 3.5 mm (average ~3.15 mm).

Shallow Anterior Chamber ( A C D < 2.5 ACD < 2.5 A C D < 2.5 mm):

Glaucoma Risk: Strongly warns of Primary Angle-Closure Suspect (PACS) or acute angle closure due to pupillary block or plateau iris configuration.

Cataract Surgical Difficulty: Severely restricts operating space in the anterior chamber. The phacoemulsification tip operates dangerously close to the corneal endothelium, dramatically escalating the risk of thermal wound burns and permanent endothelial cell destruction.

Phakic IOL Contraindication: Implantation of anterior chamber phakic IOLs (e.g., Artisan) requires a minimum internal aqueous ACD of ≥ 3.0 mm ; posterior chamber collamer lenses (ICL) mandate a minimum internal ACD of ≥ 2.8 mm to prevent angle crowding or endothelial touch.

Deep Anterior Chamber ( A C D > 4.0 ACD > 4.0 A C D > 4.0 mm): Commonly observed in high axial myopia, aphakia, or posterior crystalline lens subluxation (e.g., Marfan syndrome, pseudoexfoliation zonular laxity).